Results 111 to 120 of about 162,707 (386)

Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers

BMC Cancer, 2018
In the intensity-modulated radiotherapy (IMRT) era, great improvement has been made in survival of nasopharyngeal carcinoma (NPC). The 7th edition of the International Union against Cancer/American Joint Committee on Cancer (UICC/AJCC) staging system ...
Xingli Yang, Yan Wang, S. Liang, Sha-sha He, Dan-Ming Chen, Haiyang Chen, Lixia Lu, Yong Chen   +7 more
semanticscholar   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Comparison of simple and complex liver intensity modulated radiotherapy

Radiation Oncology, 2010
Background Intensity-modulated radiotherapy (IMRT) may allow improvement in plan quality for treatment of liver cancer, however increasing radiation modulation complexity can lead to increased uncertainties and requirements for quality assurance.
Eccles Cynthia L, Purdie Thomas G, Lee Mark T, Sharpe Michael B, Dawson Laura A   +4 more
doaj   +1 more source

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.

The Lancet Oncology, 2022
A. Tree, P. Ostler, H. van der Voet, W. Chu, A. Loblaw, D. Ford, S. Tolan, Suneil Jain, Alexander S. Martin, J. Staffurth, J. Armstrong, P. Camilleri, K. Kancherla, J. Frew, A. Chan, I. Dayes, A. Duffton, D. Brand, D. Henderson, K. Morrison, S. Brown, J. Pugh, S. Burnett, M. Mahmud, V. Hinder, O. Naismith, E. Hall, N. Van As   +27 more
semanticscholar   +1 more source

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma [PDF]

, 2020
Jingjing Zhao, Tongda Lei, Tian Zhang, Xi Chen, Jie Dong, Yong Guan, Jing Wang, Hui Wei, Puchun Er, Dong Han, Xiaoying Wei, Zhoubo Guo, Qingwu Du, Jun Wang, Ningbo Liu, Yongchun Song, Zhiyong Yuan, Lujun Zhao, Wencheng Zhang, Qingsong Pang, Ping Wang   +20 more
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A systematic review and meta-analysis

PLoS ONE, 2018
Objectives To compare clinical outcomes of concurrent chemoradiotherapy (CCRT) with those of radiotherapy alone for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy (IMRT) era.
Fang Liu, T. Jin, Lei Liu, Z. Xiang, R. Yan, Hui-jie Yang   +5 more
semanticscholar   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

A dose homogeneity and conformity evaluation between ViewRay and pinnacle-based linear accelerator IMRT treatment plans

Journal of Medical Physics, 2014
ViewRay, a novel technology providing soft-tissue imaging during radiotherapy is investigated for treatment planning capabilities assessing treatment plan dose homogeneity and conformity compared with linear accelerator plans.
Daniel L Saenz, Bhudatt R Paliwal, John E Bayouth   +2 more
doaj   +1 more source

The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis

Theranostics, 2017
Purpose: We used randomized trials of radiotherapy (RT) with or without chemotherapy in non-metastatic nasopharyngeal carcinoma to investigate the survival benefit of chemoradiotherapy regimens between two/three-dimensional radiotherapy (2D/3D RT) and ...
Rui You, Ying Cao, Pei-yu Huang, Lei Chen, Qi Yang, You-Ping Liu, X. Zou, Yi-Nuan Zhang, Rou Jiang, Mengxia Zhang, Chongyang Duan, A. Lin, M. Hong, Ming-Yuan Chen   +13 more
semanticscholar   +1 more source